<--- Back to Details
First PageDocument Content
Circulatory system / Biotechnology / Angiology / Aging-associated diseases / Emerging technologies / Stem cell treatments / Cell therapy / Angiogenesis / Embryonic stem cell / Biology / Stem cells / Medicine
Date: 2013-12-03 09:37:50
Circulatory system
Biotechnology
Angiology
Aging-associated diseases
Emerging technologies
Stem cell treatments
Cell therapy
Angiogenesis
Embryonic stem cell
Biology
Stem cells
Medicine

Add to Reading List

Source URL: pluristem.com

Download Document from Source Website

File Size: 124,37 KB

Share Document on Facebook

Similar Documents

Large ElectronPositron Collider

Biotechnology, BS "DBEFNJD.BQ  5IF"DBEFNJD.BQTFSWFTBTBTVHHFTUFEDPVSTFTFRVFODFPOMZ4UVEFOUTBSFOPUMJNJUFEUPUIJTQMBOJUJTNFBOUUPCFVTFEBT

DocID: 1xTqy - View Document

PDF Document

DocID: 1wroO - View Document

Building A Better Mousetrap: Patenting Biotechnology In The European Community

DocID: 1vr7C - View Document

BIOTECH & PHARMA IN FRANCE KEY FACTS & FIGURES ¾¾ The French biotechnology sector ranks number 3 in Europe with more than 400 companies behind the UK and Germany ¾¾ First producer of medicines in Europe with 220 prod

DocID: 1vq6b - View Document

Biotechnology Consultation Agency Response Letter BNF

DocID: 1vpUZ - View Document